Organization: Centre for Drug Research and Development (CDRD)

The Short Report, July 10, 2019: Nuclear power, future skills, health tech

A planned $100-million infusion for Alberta’s artificial intelligence sector — promised in February by then-governing NDP leader Rachel Notley — is on hold, as Premier Jason Kenney’s United Conservative Party scrutinizes the investment. Edmonton-based AI hub Amii (Alberta Machine Intelligence Institute) was slated to to use some of the funds to open a Calgary office, but…

CDRD, MNI and Merck join forces to develop new therapeutics

Two research institutes and a multinational pharmaceutical firm are partnering to launch NeuroCDRD, a novel drug development platform that aims to accelerate the development of therapeutics for debilitating neurological diseases such as Parkinson’s disease and amyotrophic lateral sclerosis. The Centre for Drug Research and Development (CDRD) will contribute its translational expertise while the Montreal Neurological…

TRIUMF Innovations launches UBC-based facility’s commercialization arm

TRIUMF has revamped and renamed its commercialization arm in a bid to boost the industrial uptake of its research and discoveries. Formerly known as Advanced Applied Physics Solutions Inc (AAPS), TRIUMF Innovations will be led by recently recruited Kathryn Hayashi who previously served as the founding CFO of the Centre for Drug Research and Development…

Microbion Corp received US$25 million in venture funding

Vancouver and Bozeman MT-based -based Microbion Corp has received US$25-million in venture capital to further develop its lead compound for the treatment of antibiotic-resistant infections. The funding is being provided by the Global Health Sciences Venture Fund, a US$500-million joint venture between Vancouver’s Quark Venture Inc and GF Securities, a Hong Kong-based investment bank. The…